| Document |
Document Title |
|
WO/2013/134877A1 |
The present application provides salen indium catalysts of the following general structure (Formula (I)), and the corresponding dimers. The salen indium catalysts are particularly useful in catalyzing ring-opening polymerizations of cycl...
|
|
WO/2013/133343A1 |
The purpose of the present invention is to provide a fluorine-containing α,β-unsaturated aldehyde, a method for producing same, an optically active fluorine-containing compound using the fluorine-containing α,β-unsaturated aldehyde, ...
|
|
WO/2013/129242A1 |
The present invention addresses the problem of providing: an imine compound which is a surfactant that is usable in emulsion polymerization and is able to be easily decomposed after use by means of a weak acid such as an organic acid; an...
|
|
WO/2013/125324A1 |
The present invention addresses the problem of providing a process for preparing an oxime in a high yield by ammoximating a ketone with both an organic peroxide and ammonia. This process is characterized by ammoximating a ketone with an ...
|
|
WO/2013/113915A1 |
This invention relates to novel processes for synthesizing N-(4-cyclohexyl-3-trifluoromethyl-benzyloxy)-acetimidic acid ethyl ester and to the compound of formula I and other intermediates that are used in such processes.
|
|
WO/2013/115195A1 |
Provided are: a curable composition able to form a cured film having lyophobic properties able to be sufficiently caused to be lyophilic even if irradiated by ultraviolet rays at a wavelength of at least 300 nm, and having favorable insu...
|
|
WO/2013/105342A1 |
The present invention relates to an evaporator that includes: a plurality of heating tubes; an upper tube plate that supports the plurality of heating tubes with spaces therebetween; and a first dispersion plate provided above the upper ...
|
|
WO/2013/091062A2 |
The present invention comprises aldimine-derived compounds, pharmaceutical compositions containing such compounds and pharmaceutically acceptable excipients, beside the use thereof for treating fungal infections of medicinal and/or veter...
|
|
WO/2013/087770A1 |
The present invention relates to quinone direct dyes of formula (I) below, organic or mineral acid or base salts thereof,tautomeric forms, optical isomers or geometrical isomers thereof and/or solvates thereof: and also to the use thereo...
|
|
WO/2013/086354A1 |
The present invention relates to a cationic lipid having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for ...
|
|
WO/2013/075199A1 |
The present invention relates to acyl-hydrazone compounds, in particular 3,4,5-trimethoxyphenyl-hydrazide derivatives, as well as the oxadiazole analogs thereof and other similar compounds, and to the pharmaceutical use of the same for t...
|
|
WO/2013/067646A1 |
The present application provides processes and intermediates useful in the production of β- aminocarbonyl- or β-aminothiocarbonyl-containing compounds. Provided herein is a process for synthesizing β-aminocarbonyl- or β-aminothiocarb...
|
|
WO/2013/061724A1 |
Provided are a novel radical inhibitor, a composition containing the same, and a radical generation inhibition method using the same. This radical inhibitor comprises a salen complex compound of a divalent metal.
|
|
WO/2013/060653A1 |
This invention relates to novel 1-cycloalkyl- or l-heterocyclyl-hydroxyimino-3-phen propanes of the formula wherein R1 to R7 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These...
|
|
WO/2013/046781A1 |
The invention pertains to a compound shown by the formula (I) and a process for the manufacture thereof. (In the formula, Ax represents an organic group having 2-30 carbon atoms having at least one aromatic ring of an aromatic hydrocarbo...
|
|
WO/2013/038136A1 |
Bi- and tri-aromatic compounds of the formula (I) wherein R1 to RIO and X are as defined, are Nox2 inhibitors that are useful as medicaments for the treatment of a disease or condition selected from: cardiovascular diseases, respiratory ...
|
|
WO/2013/035359A1 |
A first platinum complex in which two bidentate ligands are coordinated with platinum, wherein each of the two bidentate ligands has an imino moiety, nitrogen atoms in the imino moieties are coordinated with platinum at a trans position ...
|
|
WO/2013/026942A1 |
The invention provides combretastatin A-4 like compounds that are modified to have enhanced tubulin binding activity and in some embodiments the ability to promote accumulation in the vasculature undergoing angiogenesis (homing activity)...
|
|
WO/2013/020896A1 |
Group 4 transition metal complexes of bidentate iminonaphthol pro-ligands are claimed. These can be used as catalysts to polymerise olefins, preferably ethylene, inter alia to prepare ultra high molecular weight polyethylene having a nar...
|
|
WO/2013/014997A1 |
A novel metal salen complex compound having auto-magnetic properties, and a derivative thereof are provided. The present invention is a metal salen complex compound comprising any of the listed compounds.
|
|
WO/2012/176679A1 |
The invention is a polymerizable compound represented by formula (I); a polymerizable composition comprising the polymerizable compound and a polymerization initiator; a polymer obtained by polymerizing the polymerizable compound or poly...
|
|
WO/2012/172892A1 |
Provided are: a metal salen complex compound which has excellent non-invasive nature and can be efficiently delivered to an affected part; a local anesthetic which contains the metal salen complex compound; and an anti-malignant tumor ag...
|
|
WO/2012/173222A1 |
Provided are a radioactive gallium-labeled drug, which comprises gallium 67 or gallium 68 and a complex having a complex structure formed from trisalicylaldiminomethyl-ethanol bonded to a compound that bonds with the target molecules, an...
|
|
WO/2012/169424A1 |
The invention provides a polymerizable compound expressed by the following formula (I), a polymerizable composition containing the polymerizable compound and a polymerization initiator, a polymer obtained by polymerizing the polymerizabl...
|
|
WO/2012/169474A1 |
[Problem] To provide a method for producing a compound having excellent activity as an α2δ ligand. [Solution] This method for producing a compound or a salt thereof having the general formula (VI) via an iminium salt. [In the formula, ...
|
|
WO/2012/159213A1 |
There are provided compounds comprising optionally substituted (FORMULA I) fused with one or two optionally substituted (FORMULA II), wherein A and E each independently represent -CH 2 -, -NH-, -O-, -S-, or -C(=O)- and B represents a bon...
|
|
WO/2012/155764A1 |
An α-diimine metal complex catalyst, wherein the metal may be nickel or palladium. The catalyst may be used for direct catalytic polymerization of olefins to provide the olefin polymer, further preparing the highly branched alkane mixtu...
|
|
WO/2012/147398A1 |
The purpose of the present invention is to provide an anthraquinone derivative whereby it is possible to simultaneously achieve a weight reduction, capacity increase, and service life extension (cycle suitability) in a lithium ion second...
|
|
WO/2012/147904A1 |
The present invention relates to a polymerizable compound indicated by formula (I). The present invention provides a polymerizable compound, a polymerizable composition, a polymer, and an optically anisotropic material that are capable o...
|
|
WO/2012/141245A1 |
The present invention provides: a polymerizable compound represented by formula (I); a polymerizable composition containing said polymerizable compound and a polymerization initiator; a polymer obtained by polymerizing said polymerizable...
|
|
WO/2012/141038A1 |
The purpose is to select a low-molecular-weight compound which is effective for inducing the differentiation of a mesenchymal stem cell into a hepatocyte and develop a differentiation-inducing method which has excellent efficiency of ind...
|
|
WO/2012/122854A1 |
Disclosed in the present invention are an asymmetric (α-diimine) nickel complex catalyst and preparation method and use thereof. The complex is as shown in formula I, wherein Rl is a diphenylmethyl, R2 is methyl or diphenylmethyl, R3 is...
|
|
WO/2012/118216A1 |
The present invention addresses the problem of providing an auxin biosynthesis inhibitor superior to L-AOPP. The foregoing problem can be solved by a compound of general formula (I) (in the formula, R1-R5 and X are as set forth in the sp...
|
|
WO/2012/116311A2 |
Provided are methods using ketoximes and/or aldoximes, including 3-methyl-5- alkylsalicyialdoxime and/or 3-methyl-5-alkyl-2-hydroxyacetophenone oxime, in reagent compositions for metal extraction/isolation. One such method is of extracti...
|
|
WO/2012/111380A1 |
The molecular structure of a metal salen complex erxhibiting a pharmacological effect has been clarified, and provided are a metal salen complex provided with such a molecular structure, as well as a derivative of the complex. A metal sa...
|
|
WO/2012/108367A1 |
A quaternary ammonium salt shown by formula (5) (in the formula, R1 represents a C1-4 alkyl group; R2 represents a C1-10 alkyl group; R3 represents a C1-10 alkyl group optionally substituted with one or more phenyl groups or a phenyl gro...
|
|
WO/2012/109343A2 |
Provided are methods of preparing polymers, such as polyisoprene, polybutadiene, polypiperylene, polycyclohexadiene, poly-β-farnesene, or poly-β-myrcene, using iron complexes. Also provided are novel iron complexes, pre-catalysts, inte...
|
|
WO/2012/101139A1 |
The invention relates to a process for the preparation of 3-difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxylic acid (9-dichloromethylene-1,2,3,4-tetrahydro-1,4-methano-naphthal
en-5-yl)-amide by acylating the oxime oxygen of the compound...
|
|
WO/2011/020883A9 |
The present invention relates to compounds suitable for modulating huntingtin protein processing and useful for treating or preventing huntingtin-related disorders. The invention provides pharmaceutical compositions comprising said compo...
|
|
WO/2012/091379A2 |
Provided is a novel diimmonium-based component having low light absorption in the visible region and superior light absorption efficiency in the near infrared region, and having superior durability and weather resistance, as well as a ne...
|
|
WO/2012/085189A1 |
The invention relates to compounds of general formula (I) wherein R is (C1-C7)alkyl, (C2-C7)alkenyl or (C2-C7)alkynyl; wherein R is substituted with R1; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use -alone...
|
|
WO/2012/086683A1 |
The present invention provides a metal-salen complex compound comprising controlled particle diameters, in order to exhibit pharmacological effects as a medicine in a target area. The metal-salen complex compound is configured from chemi...
|
|
WO/2012/072736A2 |
The present invention relates to the field of radiopharmaceuticals for in vivo imaging, in particular to a method of labelling a biological targeting molecule with a radioisotope. The method of the invention is particularly suitable for ...
|
|
WO/2012/074168A1 |
The present invention relates to a method for preparing MHB (methyl-4-hydroxyiminobenzoate) from by-products generated in a process for preparing DMT (dimethyl terephthalate). The method comprises: (a) adding alcohol to reaction by-produ...
|
|
WO/2012/063663A1 |
Provided is an organic electroluminescent element that exhibits high luminous efficiency. This organic electroluminescent element has a first electrode, at least one organic layer containing a light emitting layer that contains at least ...
|
|
WO/2012/059436A2 |
The invention relates to novel compounds of formula (I), in which R1, R2, R3, R4, R5, Y, Q and G are defined as indicated above, to several methods and intermediate products for the production thereof and use thereof as herbicides and/or...
|
|
WO/2012/057135A1 |
The present invention provides: a catalyst for norbornene polymerization, which contains a transition metal complex (A) that is represented by general formula (1); and a method for producing a norbornene (co)polymer, especially a norborn...
|
|
WO/2012/055894A1 |
The present invention relates to new diterpenoid derivatives of formula (I), processes for their preparation, and to pharmaceutical compositions containing them for the treatment of cardiovascular disorders, urinary incontinence, asthma,...
|
|
WO/2012/057709A1 |
Compounds of formula (I): wherein R1 to R8, and X- are defined herein. Also disclosed are methods of making and using these compounds.
|
|
WO/2012/031735A1 |
The present invention relates to an organic solar cell comprising new truxequinone derivatives used as acceptor, electron transport material, and doped electron transport materials.
|
